Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
No Data
Revenue and Profits:
Net Sales:
17,933 Million
(Quarterly Results - Mar 2026)
Net Profit:
329 Million
Pharmaceuticals & Biotechnology
JPY 510,998 Million (Mid Cap)
59.00
NA
0.00%
0.38
11.22%
5.84






